NanoViricides Inc NNVC:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/14/21 EDT
3.46quote price arrow up+0.04 (+1.17%)
Volume
1,587
Close
3.42quote price arrow up+0.32 (+10.32%)
Volume
145,716
52 week range
2.85 - 12.20

...

Loading . . .
  • Open3.15
  • Day High3.48
  • Day Low3.15
  • Prev Close3.10
  • 52 Week High12.20
  • 52 Week High Date05/14/20
  • 52 Week Low2.85
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap36.53M
  • Shares Out10.68M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change19.16

KEY STATS

  • Open3.15
  • Day High3.48
  • Day Low3.15
  • Prev Close3.10
  • 52 Week High12.20
  • 52 Week High Date05/14/20
  • 52 Week Low2.85
  • 52 Week Low Date12/31/20
  • Market Cap36.53M
  • Shares Out10.68M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta0.90
  • YTD % Change19.16

RATIOS/PROFITABILITY

  • EPS (TTM)-1.91
  • P/E (TTM)-1.79
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-8.234M
  • ROE (MRQ)-82.32%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/31/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On NanoViricides Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously...
Anil Diwan Ph.D.
Chairman
Meeta Vyas
Chief Financial Officer
Address
1 Controls Drive
Shelton, CT
06484
United States

Top Peers

SYMBOLLASTCHG%CHG
TRVI
Trevi Therapeutics Inc
2.06+0.05+2.49%
BLPH
Bellerophon Therapeutics Inc
3.94+0.11+2.87%
CATB
Catabasis Pharmaceuticals Inc
1.78+0.04+2.30%
ACER
Acer Therapeutics Inc
2.63+0.11+4.37%
CYCC
Cyclacel Pharmaceuticals Inc
6.79+0.23+3.51%